Sir paul girolami biography youtube

Paul Girolami

Italian-British businessman (–)

Sir Paul GirolamiFREconS FIMC (25 January – 17 March ) was an Italian-British businessman, who was chairman and chief executive of Glaxo; he made Glaxo into a worldwide success.

Early life and career

Girolami was born in Italy on 25 January [1] He attended the London School of Economics.

Girolami joined Glaxo in as a Financial Controller.

Sir paul girolami biography Sir Paul Girolami FREconS FIMC (25 January – 17 March ) was an Italian-British businessman, who was chairman and chief executive of Glaxo; he made Glaxo into a worldwide success. Early life and career.

He became finance director in when aged In April it was announced that he would become chief executive. In the early s, Glaxo briefly surpassed British Telecom to become Britain's most valued company on the stock market (LSE), and Glaxo was the world's second-largest pharmaceutical company and remained so into the s; it had been 25th largest in the world in The reasons for this were a huge increase in its R&D budget, and employing many more researchers; by it was spending $ million on research with around 5, researchers, of which 3, were in the UK.

Its other researchers were in Italy, the US and Japan. In April he was appointed deputy chairman, and it was announced that he would be leaving his post as chief executive in early On 10 December , he became chairman of Glaxo. He left as chairman in November , when aged [2]

Glaxo merged to become Glaxo Wellcome a year later in Glaxo drugs that sold well included the Fortum (ceftazidime) and Zinnat (cefuroxime axetil) antibiotics.

Personal life and death

Girolami married in ; his wife died in They had two sons and a daughter. He was knighted in the New Year Honours, when chairman of Glaxo Holdings.[3]

Girolami died on 15 March , at the age of [4]

See also

References

External links

Business positions
Preceded&#;by

Sir Austin Bide

Chairman of Glaxo Holdings
Succeeded&#;by
Preceded&#;by

Sir Austin Bide

Chief Executive of Glaxo Holdings
Succeeded&#;by

Bernard Taylor

Preceded&#;by Finance Director of Glaxo Holdings
Succeeded&#;by